22-41141230-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001429.4(EP300):​c.2053+8G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.994 in 1,613,534 control chromosomes in the GnomAD database, including 797,225 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 71357 hom., cov: 33)
Exomes 𝑓: 1.0 ( 725868 hom. )

Consequence

EP300
NM_001429.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00001963
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.06

Publications

16 publications found
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300-AS1 (HGNC:50504): (EP300 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 22-41141230-G-T is Benign according to our data. Variant chr22-41141230-G-T is described in ClinVar as Benign. ClinVar VariationId is 93732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EP300NM_001429.4 linkc.2053+8G>T splice_region_variant, intron_variant Intron 10 of 30 ENST00000263253.9 NP_001420.2 Q09472Q7Z6C1
EP300NM_001362843.2 linkc.2053+8G>T splice_region_variant, intron_variant Intron 10 of 29 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkc.2053+8G>T splice_region_variant, intron_variant Intron 10 of 30 1 NM_001429.4 ENSP00000263253.7 Q09472

Frequencies

GnomAD3 genomes
AF:
0.967
AC:
147104
AN:
152202
Hom.:
71306
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.883
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.988
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.994
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.980
GnomAD2 exomes
AF:
0.991
AC:
249073
AN:
251244
AF XY:
0.994
show subpopulations
Gnomad AFR exome
AF:
0.878
Gnomad AMR exome
AF:
0.996
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.996
GnomAD4 exome
AF:
0.997
AC:
1456183
AN:
1461214
Hom.:
725868
Cov.:
38
AF XY:
0.997
AC XY:
724801
AN XY:
726910
show subpopulations
African (AFR)
AF:
0.874
AC:
29226
AN:
33458
American (AMR)
AF:
0.996
AC:
44503
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26132
AN:
26132
East Asian (EAS)
AF:
1.00
AC:
39692
AN:
39692
South Asian (SAS)
AF:
1.00
AC:
86158
AN:
86176
European-Finnish (FIN)
AF:
1.00
AC:
53406
AN:
53406
Middle Eastern (MID)
AF:
0.997
AC:
5753
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111372
AN:
1111508
Other (OTH)
AF:
0.993
AC:
59941
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
211
422
633
844
1055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21654
43308
64962
86616
108270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.966
AC:
147214
AN:
152320
Hom.:
71357
Cov.:
33
AF XY:
0.968
AC XY:
72082
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.883
AC:
36676
AN:
41538
American (AMR)
AF:
0.988
AC:
15122
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5193
AN:
5194
South Asian (SAS)
AF:
1.00
AC:
4830
AN:
4832
European-Finnish (FIN)
AF:
1.00
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
0.993
AC:
292
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68031
AN:
68050
Other (OTH)
AF:
0.980
AC:
2068
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
242
483
725
966
1208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.983
Hom.:
33510
Bravo
AF:
0.962
Asia WGS
AF:
0.994
AC:
3456
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 02, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Menke-Hennekam syndrome 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.21
DANN
Benign
0.44
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000020
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6002267; hg19: chr22-41537234; API